The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.

作者: W John Edmunds , Marc Brisson , Alessia Melegaro , Nigel J Gay , None

DOI: 10.1016/S0264-410X(01)00473-X

关键词: VaccinationCost effectivenessPediatricsMortality rateEconomic evaluationBooster (rocketry)EpidemiologyWhooping coughAcellular pertussisMedicine

摘要: A cost-effectiveness analysis of the introduction acellular pertussis booster doses at either 4 or 15 years age was performed. transmission dynamic model used to predict level indirect protection in those too young be vaccinated. Multivariate sensitivity analyses were In England and Wales there are an estimated 35,000 general practitioner (GP) consultations, 5500 inpatient days, nine deaths annually attributable pertussis, despite high levels coverage for primary course (approximately 95%). Around 80% bed-days 90% occur immunised (< 3 months age). The is expected reduce morbidity mortality younger groups by 40-100%, 0-100%. From perspective health care provider, roughly 50% simulations result a cost per life-year gained less than 10,000 pounds vaccination years, corresponding proportion being only 35%. Apart from degree most sensitive discount rate, price vaccine, rate. Significant uncertainty remains regarding epidemiology impact doses. Nevertheless, boosters, particularly has potential cost-effective UK.

参考文章(39)
Paul F Thomas, Peter B Mcintyre, Bin B Jalaludln, Survey of pertussis morbidity in adults in western Sydney. The Medical Journal of Australia. ,vol. 173, pp. 74- 76 ,(2000) , 10.5694/J.1326-5377.2000.TB139246.X
T. S. J. Elliott, D. M. Fleming, L. A. E. Ashworth, D. A. Mabbett, J. E. Vurdien, E. Miller, Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Communicable disease and public health. ,vol. 3, pp. 132- 134 ,(2000)
D. W. Maclean, Adults with pertussis. The Journal of the Royal College of General Practitioners. ,vol. 32, pp. 298- 300 ,(1982)
Nicolas Meeùs, Malou M-Louise Haine, Van Damme A. P. Mardaga. pp. 416- 417 ,(1986)
Robert M. May, Roy M. Anderson, Infectious Diseases of Humans: Dynamics and Control ,(1991)
Seth W Wright, Kathryn M Edwards, Michael D Decker, Marie H Zeldin, Pertussis Infection in Adults With Persistent Cough JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 1044- 1046 ,(1995) , 10.1001/JAMA.1995.03520370086042
JACQUELINE A CLARKSON, PAUL E M FINE, The Efficiency of Measles and Pertussis Notification in England and Wales International Journal of Epidemiology. ,vol. 14, pp. 153- 168 ,(1985) , 10.1093/IJE/14.1.153
Jeffrey P. Koplan, Stephen C. Schoenbaum, Milton C. Weinstein, David W. Fraser, Pertussis Vaccine — An Analysis of Benefits, Risks and Costs New England Journal of Medicine. ,vol. 301, pp. 906- 911 ,(1979) , 10.1056/NEJM197910253011703
Michael Iskedjian, Thomas R. Einarson, Bernie J. O??Brien, J. Gaston De Serres, Ron Gold, Ian M. Gemmill, Natalie Milkovich, Andrew Rosner, Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada PharmacoEconomics. ,vol. 19, pp. 551- 563 ,(2001) , 10.2165/00019053-200119050-00009
S. S. Long, C. J. Welkon, J. L. Clark, Widespread Silent Transmission of Pertussis in Families: Antibody Correlates of Infection and Symptomatology The Journal of Infectious Diseases. ,vol. 161, pp. 480- 486 ,(1990) , 10.1093/INFDIS/161.3.480